Vimarsana
Biggest News Aggregation in the World

Comparative Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comparative Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comparative Effectiveness Today - Breaking & Trending Today

UAB researchers part of GRADE study investigating glucose medications in Type 2 diabetes - Vimarsana News

UAB researchers part of GRADE study investigating glucose medications in Type 2 diabetes

UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients. University o...

Source: uab.edu
Targeted Therapy Associated With Lower SPM Risk Among Treated Patients With CLL - Vimarsana News

Targeted Therapy Associated With Lower SPM Risk Among Treated Patients With CLL

Investigators found patients receiving chemotherapy had a greater risk of a secondary primary malignancy (SPM) compared with those treated with targeted therapies or those whose chronic lymphocytic leukemia (CLL) was left untreated.

Source: ajmc.com
Behavioral activation vs antidepressants: Which wins for heart failure patients with depression? - Vimarsana News

Behavioral activation vs antidepressants: Which wins for heart failure patients with depression?

The efficacy of antidepressant medication management (MEDS) against behavioral activation psychotherapy (BA).

Sotatercept Endorsed for PAH by ICER - Vimarsana News

Sotatercept Endorsed for PAH by ICER

Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.

SK Life Science to Host Symposium and Present New Data at the American Epilepsy Society (AES) 2023 Annual Meeting - Vimarsana News

SK Life Science to Host Symposium and Present New Data at the American Epilepsy Society (AES) 2023 Annual Meeting

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and oncology, will present data on cenobamate at the American Epilepsy Society (AES) Annual Meeting, to be held December 1-5, 2023, in Orlando, Florida.

Source: yahoo.com